• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » HRS 2015: Boston Scientific touts cost-saving data for Watchman

HRS 2015: Boston Scientific touts cost-saving data for Watchman

May 14, 2015 By Brad Perriello

HRS 2015: Boston Scientific touts cost-saving data for Watchman

Boston Scientific (NYSE:BSX) yesterday presented data it said shows the cost-effectiveness of its Watchman anti-stroke device compared with the blood-thinning drugs warfarin or aspirin.

"It’s actually really straightforward," Stacey Amorosi, senior manager for health economics, told MassDevice.com last night at the annual meeting of the Heart Rhythm Society in Boston. "You’re faced with the up-front, 1-time cost of the [Watchman] procedure. That initial cost impact is pretty quickly eroded by [the cost of] complications from Warfarin and aspirin."

The study, "Medicare Budget Implications of 3 Stroke Risk Reduction Strategies in Non-valvular Atrial Fibrillation," found that the Watchman left atrial appendage closure device was less expensive than aspirin at 6 years and warfarin at 7 years. Over 10 years, treatment with the Watchman device saved an average $10,00 per patient compared with warfarin and nearly $19,000 compared with aspirin, according to the study.

Boston is bullish on the Watchman device, with CEO Mike Mahoney saying there’s "a big unmet need" among atrial fibrillation patients who can’t or won’t tolerate the anti-coagulant drugs.

The FDA approved Watchman in March only after an unprecedented 3 advisory panel meetings to evaluate the device.

"There were many patients waiting for this to be approved in the United States,"Mahoney said last month.

Filed Under: Cardiac Implants, News Well Tagged With: Boston Scientific, Clinical Trials, Stroke

More recent news

  • China reportedly launches country’s first invasive BCI trial
  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy